nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—Paget's disease of bone—bone cancer	0.891	1	CtDrD
Pamidronate—FDPS—jaw skeleton—bone cancer	0.0127	0.465	CbGeAlD
Pamidronate—FDPS—periosteum—bone cancer	0.00956	0.351	CbGeAlD
Pamidronate—FDPS—connective tissue—bone cancer	0.00167	0.0612	CbGeAlD
Pamidronate—FDPS—tendon—bone cancer	0.00115	0.042	CbGeAlD
Pamidronate—FDPS—bone marrow—bone cancer	0.00111	0.0407	CbGeAlD
Pamidronate—FDPS—spinal cord—bone cancer	0.0011	0.0405	CbGeAlD
Pamidronate—Risedronate—PTGS2—bone cancer	0.000845	0.396	CrCbGaD
Pamidronate—Clodronate—PTGS2—bone cancer	0.000753	0.353	CrCbGaD
Pamidronate—Histamine Phosphate—CYP3A4—bone cancer	0.000538	0.252	CrCbGaD
Pamidronate—Paraesthesia—Cisplatin—bone cancer	0.000157	0.00197	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Methotrexate—bone cancer	0.000157	0.00197	CcSEcCtD
Pamidronate—Liver function test abnormal—Doxorubicin—bone cancer	0.000156	0.00196	CcSEcCtD
Pamidronate—Dyspnoea—Cisplatin—bone cancer	0.000156	0.00195	CcSEcCtD
Pamidronate—Hypokalaemia—Doxorubicin—bone cancer	0.000154	0.00193	CcSEcCtD
Pamidronate—Decreased appetite—Cisplatin—bone cancer	0.000152	0.0019	CcSEcCtD
Pamidronate—Pneumonia—Methotrexate—bone cancer	0.000151	0.0019	CcSEcCtD
Pamidronate—Nasopharyngitis—Doxorubicin—bone cancer	0.000151	0.00189	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Cisplatin—bone cancer	0.000151	0.00189	CcSEcCtD
Pamidronate—Infestation—Methotrexate—bone cancer	0.00015	0.00189	CcSEcCtD
Pamidronate—Infestation NOS—Methotrexate—bone cancer	0.00015	0.00189	CcSEcCtD
Pamidronate—Gastritis—Doxorubicin—bone cancer	0.000149	0.00187	CcSEcCtD
Pamidronate—Pain—Cisplatin—bone cancer	0.000149	0.00187	CcSEcCtD
Pamidronate—Renal failure—Methotrexate—bone cancer	0.000148	0.00185	CcSEcCtD
Pamidronate—Neutropenia—Epirubicin—bone cancer	0.000147	0.00185	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Epirubicin—bone cancer	0.000146	0.00184	CcSEcCtD
Pamidronate—Stomatitis—Methotrexate—bone cancer	0.000146	0.00184	CcSEcCtD
Pamidronate—Conjunctivitis—Methotrexate—bone cancer	0.000146	0.00183	CcSEcCtD
Pamidronate—Influenza—Doxorubicin—bone cancer	0.000146	0.00183	CcSEcCtD
Pamidronate—Feeling abnormal—Cisplatin—bone cancer	0.000144	0.00181	CcSEcCtD
Pamidronate—Haematuria—Methotrexate—bone cancer	0.000143	0.0018	CcSEcCtD
Pamidronate—Pneumonia—Epirubicin—bone cancer	0.000141	0.00177	CcSEcCtD
Pamidronate—Infestation NOS—Epirubicin—bone cancer	0.000141	0.00176	CcSEcCtD
Pamidronate—Infestation—Epirubicin—bone cancer	0.000141	0.00176	CcSEcCtD
Pamidronate—Agranulocytosis—Methotrexate—bone cancer	0.00014	0.00176	CcSEcCtD
Pamidronate—Renal failure—Epirubicin—bone cancer	0.000138	0.00173	CcSEcCtD
Pamidronate—Body temperature increased—Cisplatin—bone cancer	0.000138	0.00173	CcSEcCtD
Pamidronate—Stomatitis—Epirubicin—bone cancer	0.000137	0.00172	CcSEcCtD
Pamidronate—Conjunctivitis—Epirubicin—bone cancer	0.000137	0.00172	CcSEcCtD
Pamidronate—Urinary tract infection—Epirubicin—bone cancer	0.000137	0.00172	CcSEcCtD
Pamidronate—Neutropenia—Doxorubicin—bone cancer	0.000136	0.00171	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000136	0.0017	CcSEcCtD
Pamidronate—Haemoglobin—Methotrexate—bone cancer	0.000135	0.0017	CcSEcCtD
Pamidronate—Haemorrhage—Methotrexate—bone cancer	0.000135	0.00169	CcSEcCtD
Pamidronate—Haematuria—Epirubicin—bone cancer	0.000134	0.00168	CcSEcCtD
Pamidronate—Urinary tract disorder—Methotrexate—bone cancer	0.000133	0.00167	CcSEcCtD
Pamidronate—Urethral disorder—Methotrexate—bone cancer	0.000132	0.00166	CcSEcCtD
Pamidronate—Sinusitis—Epirubicin—bone cancer	0.000132	0.00166	CcSEcCtD
Pamidronate—Agranulocytosis—Epirubicin—bone cancer	0.000131	0.00165	CcSEcCtD
Pamidronate—Pneumonia—Doxorubicin—bone cancer	0.000131	0.00164	CcSEcCtD
Pamidronate—Infestation NOS—Doxorubicin—bone cancer	0.00013	0.00163	CcSEcCtD
Pamidronate—Infestation—Doxorubicin—bone cancer	0.00013	0.00163	CcSEcCtD
Pamidronate—Hypersensitivity—Cisplatin—bone cancer	0.000129	0.00161	CcSEcCtD
Pamidronate—Renal failure—Doxorubicin—bone cancer	0.000128	0.0016	CcSEcCtD
Pamidronate—Haemoglobin—Epirubicin—bone cancer	0.000127	0.00159	CcSEcCtD
Pamidronate—Stomatitis—Doxorubicin—bone cancer	0.000127	0.00159	CcSEcCtD
Pamidronate—Rhinitis—Epirubicin—bone cancer	0.000126	0.00159	CcSEcCtD
Pamidronate—Conjunctivitis—Doxorubicin—bone cancer	0.000126	0.00159	CcSEcCtD
Pamidronate—Urinary tract infection—Doxorubicin—bone cancer	0.000126	0.00159	CcSEcCtD
Pamidronate—Haemorrhage—Epirubicin—bone cancer	0.000126	0.00158	CcSEcCtD
Pamidronate—Eye disorder—Methotrexate—bone cancer	0.000126	0.00158	CcSEcCtD
Pamidronate—Asthenia—Cisplatin—bone cancer	0.000125	0.00157	CcSEcCtD
Pamidronate—Cardiac disorder—Methotrexate—bone cancer	0.000125	0.00157	CcSEcCtD
Pamidronate—Urinary tract disorder—Epirubicin—bone cancer	0.000125	0.00156	CcSEcCtD
Pamidronate—Haematuria—Doxorubicin—bone cancer	0.000124	0.00156	CcSEcCtD
Pamidronate—Connective tissue disorder—Epirubicin—bone cancer	0.000124	0.00156	CcSEcCtD
Pamidronate—Urethral disorder—Epirubicin—bone cancer	0.000124	0.00155	CcSEcCtD
Pamidronate—Angiopathy—Methotrexate—bone cancer	0.000122	0.00154	CcSEcCtD
Pamidronate—Sinusitis—Doxorubicin—bone cancer	0.000122	0.00153	CcSEcCtD
Pamidronate—Immune system disorder—Methotrexate—bone cancer	0.000122	0.00153	CcSEcCtD
Pamidronate—Mediastinal disorder—Methotrexate—bone cancer	0.000121	0.00153	CcSEcCtD
Pamidronate—Agranulocytosis—Doxorubicin—bone cancer	0.000121	0.00152	CcSEcCtD
Pamidronate—Chills—Methotrexate—bone cancer	0.000121	0.00152	CcSEcCtD
Pamidronate—Diarrhoea—Cisplatin—bone cancer	0.000119	0.0015	CcSEcCtD
Pamidronate—Alopecia—Methotrexate—bone cancer	0.000119	0.0015	CcSEcCtD
Pamidronate—Eye disorder—Epirubicin—bone cancer	0.000118	0.00148	CcSEcCtD
Pamidronate—Erythema—Methotrexate—bone cancer	0.000117	0.00147	CcSEcCtD
Pamidronate—Malnutrition—Methotrexate—bone cancer	0.000117	0.00147	CcSEcCtD
Pamidronate—Haemoglobin—Doxorubicin—bone cancer	0.000117	0.00147	CcSEcCtD
Pamidronate—Cardiac disorder—Epirubicin—bone cancer	0.000117	0.00147	CcSEcCtD
Pamidronate—Flushing—Epirubicin—bone cancer	0.000117	0.00147	CcSEcCtD
Pamidronate—Rhinitis—Doxorubicin—bone cancer	0.000117	0.00147	CcSEcCtD
Pamidronate—Haemorrhage—Doxorubicin—bone cancer	0.000117	0.00147	CcSEcCtD
Pamidronate—Urinary tract disorder—Doxorubicin—bone cancer	0.000115	0.00145	CcSEcCtD
Pamidronate—Dysgeusia—Methotrexate—bone cancer	0.000115	0.00144	CcSEcCtD
Pamidronate—Connective tissue disorder—Doxorubicin—bone cancer	0.000115	0.00144	CcSEcCtD
Pamidronate—Angiopathy—Epirubicin—bone cancer	0.000114	0.00144	CcSEcCtD
Pamidronate—Urethral disorder—Doxorubicin—bone cancer	0.000114	0.00144	CcSEcCtD
Pamidronate—Immune system disorder—Epirubicin—bone cancer	0.000114	0.00143	CcSEcCtD
Pamidronate—Mediastinal disorder—Epirubicin—bone cancer	0.000114	0.00143	CcSEcCtD
Pamidronate—Back pain—Methotrexate—bone cancer	0.000114	0.00143	CcSEcCtD
Pamidronate—Chills—Epirubicin—bone cancer	0.000113	0.00142	CcSEcCtD
Pamidronate—Alopecia—Epirubicin—bone cancer	0.000111	0.0014	CcSEcCtD
Pamidronate—Vomiting—Cisplatin—bone cancer	0.000111	0.00139	CcSEcCtD
Pamidronate—Rash—Cisplatin—bone cancer	0.00011	0.00138	CcSEcCtD
Pamidronate—Dermatitis—Cisplatin—bone cancer	0.00011	0.00138	CcSEcCtD
Pamidronate—Erythema—Epirubicin—bone cancer	0.00011	0.00138	CcSEcCtD
Pamidronate—Malnutrition—Epirubicin—bone cancer	0.00011	0.00138	CcSEcCtD
Pamidronate—Eye disorder—Doxorubicin—bone cancer	0.000109	0.00137	CcSEcCtD
Pamidronate—Ill-defined disorder—Methotrexate—bone cancer	0.000109	0.00137	CcSEcCtD
Pamidronate—Anaemia—Methotrexate—bone cancer	0.000108	0.00136	CcSEcCtD
Pamidronate—Cardiac disorder—Doxorubicin—bone cancer	0.000108	0.00136	CcSEcCtD
Pamidronate—Flushing—Doxorubicin—bone cancer	0.000108	0.00136	CcSEcCtD
Pamidronate—Tension—Epirubicin—bone cancer	0.000108	0.00135	CcSEcCtD
Pamidronate—Dysgeusia—Epirubicin—bone cancer	0.000108	0.00135	CcSEcCtD
Pamidronate—Nervousness—Epirubicin—bone cancer	0.000107	0.00134	CcSEcCtD
Pamidronate—Back pain—Epirubicin—bone cancer	0.000106	0.00133	CcSEcCtD
Pamidronate—Angiopathy—Doxorubicin—bone cancer	0.000106	0.00133	CcSEcCtD
Pamidronate—Malaise—Methotrexate—bone cancer	0.000106	0.00133	CcSEcCtD
Pamidronate—Muscle spasms—Epirubicin—bone cancer	0.000106	0.00133	CcSEcCtD
Pamidronate—Immune system disorder—Doxorubicin—bone cancer	0.000105	0.00132	CcSEcCtD
Pamidronate—Mediastinal disorder—Doxorubicin—bone cancer	0.000105	0.00132	CcSEcCtD
Pamidronate—Leukopenia—Methotrexate—bone cancer	0.000105	0.00132	CcSEcCtD
Pamidronate—Chills—Doxorubicin—bone cancer	0.000105	0.00131	CcSEcCtD
Pamidronate—Nausea—Cisplatin—bone cancer	0.000104	0.0013	CcSEcCtD
Pamidronate—Alopecia—Doxorubicin—bone cancer	0.000103	0.0013	CcSEcCtD
Pamidronate—Cough—Methotrexate—bone cancer	0.000102	0.00129	CcSEcCtD
Pamidronate—Ill-defined disorder—Epirubicin—bone cancer	0.000102	0.00128	CcSEcCtD
Pamidronate—Convulsion—Methotrexate—bone cancer	0.000102	0.00128	CcSEcCtD
Pamidronate—Erythema—Doxorubicin—bone cancer	0.000102	0.00128	CcSEcCtD
Pamidronate—Malnutrition—Doxorubicin—bone cancer	0.000102	0.00128	CcSEcCtD
Pamidronate—Anaemia—Epirubicin—bone cancer	0.000102	0.00127	CcSEcCtD
Pamidronate—Agitation—Epirubicin—bone cancer	0.000101	0.00127	CcSEcCtD
Pamidronate—Myalgia—Methotrexate—bone cancer	9.99e-05	0.00125	CcSEcCtD
Pamidronate—Arthralgia—Methotrexate—bone cancer	9.99e-05	0.00125	CcSEcCtD
Pamidronate—Tension—Doxorubicin—bone cancer	9.97e-05	0.00125	CcSEcCtD
Pamidronate—Dysgeusia—Doxorubicin—bone cancer	9.95e-05	0.00125	CcSEcCtD
Pamidronate—Malaise—Epirubicin—bone cancer	9.9e-05	0.00124	CcSEcCtD
Pamidronate—Discomfort—Methotrexate—bone cancer	9.87e-05	0.00124	CcSEcCtD
Pamidronate—Nervousness—Doxorubicin—bone cancer	9.87e-05	0.00124	CcSEcCtD
Pamidronate—Syncope—Epirubicin—bone cancer	9.85e-05	0.00124	CcSEcCtD
Pamidronate—Leukopenia—Epirubicin—bone cancer	9.83e-05	0.00123	CcSEcCtD
Pamidronate—Back pain—Doxorubicin—bone cancer	9.83e-05	0.00123	CcSEcCtD
Pamidronate—Muscle spasms—Doxorubicin—bone cancer	9.77e-05	0.00123	CcSEcCtD
Pamidronate—Confusional state—Methotrexate—bone cancer	9.66e-05	0.00121	CcSEcCtD
Pamidronate—Loss of consciousness—Epirubicin—bone cancer	9.65e-05	0.00121	CcSEcCtD
Pamidronate—Cough—Epirubicin—bone cancer	9.58e-05	0.0012	CcSEcCtD
Pamidronate—Anaphylactic shock—Methotrexate—bone cancer	9.58e-05	0.0012	CcSEcCtD
Pamidronate—Convulsion—Epirubicin—bone cancer	9.52e-05	0.00119	CcSEcCtD
Pamidronate—Infection—Methotrexate—bone cancer	9.51e-05	0.00119	CcSEcCtD
Pamidronate—Hypertension—Epirubicin—bone cancer	9.48e-05	0.00119	CcSEcCtD
Pamidronate—Ill-defined disorder—Doxorubicin—bone cancer	9.43e-05	0.00118	CcSEcCtD
Pamidronate—Nervous system disorder—Methotrexate—bone cancer	9.39e-05	0.00118	CcSEcCtD
Pamidronate—Anaemia—Doxorubicin—bone cancer	9.39e-05	0.00118	CcSEcCtD
Pamidronate—Thrombocytopenia—Methotrexate—bone cancer	9.38e-05	0.00118	CcSEcCtD
Pamidronate—Myalgia—Epirubicin—bone cancer	9.35e-05	0.00117	CcSEcCtD
Pamidronate—Arthralgia—Epirubicin—bone cancer	9.35e-05	0.00117	CcSEcCtD
Pamidronate—Agitation—Doxorubicin—bone cancer	9.34e-05	0.00117	CcSEcCtD
Pamidronate—Anxiety—Epirubicin—bone cancer	9.32e-05	0.00117	CcSEcCtD
Pamidronate—Hyperhidrosis—Methotrexate—bone cancer	9.26e-05	0.00116	CcSEcCtD
Pamidronate—Discomfort—Epirubicin—bone cancer	9.24e-05	0.00116	CcSEcCtD
Pamidronate—Malaise—Doxorubicin—bone cancer	9.16e-05	0.00115	CcSEcCtD
Pamidronate—Anorexia—Methotrexate—bone cancer	9.13e-05	0.00115	CcSEcCtD
Pamidronate—Syncope—Doxorubicin—bone cancer	9.11e-05	0.00114	CcSEcCtD
Pamidronate—Leukopenia—Doxorubicin—bone cancer	9.1e-05	0.00114	CcSEcCtD
Pamidronate—Confusional state—Epirubicin—bone cancer	9.04e-05	0.00113	CcSEcCtD
Pamidronate—Anaphylactic shock—Epirubicin—bone cancer	8.96e-05	0.00113	CcSEcCtD
Pamidronate—Oedema—Epirubicin—bone cancer	8.96e-05	0.00113	CcSEcCtD
Pamidronate—Hypotension—Methotrexate—bone cancer	8.95e-05	0.00112	CcSEcCtD
Pamidronate—Loss of consciousness—Doxorubicin—bone cancer	8.93e-05	0.00112	CcSEcCtD
Pamidronate—Infection—Epirubicin—bone cancer	8.9e-05	0.00112	CcSEcCtD
Pamidronate—Cough—Doxorubicin—bone cancer	8.87e-05	0.00111	CcSEcCtD
Pamidronate—Shock—Epirubicin—bone cancer	8.82e-05	0.00111	CcSEcCtD
Pamidronate—Convulsion—Doxorubicin—bone cancer	8.8e-05	0.00111	CcSEcCtD
Pamidronate—Nervous system disorder—Epirubicin—bone cancer	8.79e-05	0.0011	CcSEcCtD
Pamidronate—Thrombocytopenia—Epirubicin—bone cancer	8.78e-05	0.0011	CcSEcCtD
Pamidronate—Hypertension—Doxorubicin—bone cancer	8.77e-05	0.0011	CcSEcCtD
Pamidronate—Tachycardia—Epirubicin—bone cancer	8.75e-05	0.0011	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Methotrexate—bone cancer	8.73e-05	0.0011	CcSEcCtD
Pamidronate—Hyperhidrosis—Epirubicin—bone cancer	8.66e-05	0.00109	CcSEcCtD
Pamidronate—Insomnia—Methotrexate—bone cancer	8.66e-05	0.00109	CcSEcCtD
Pamidronate—Myalgia—Doxorubicin—bone cancer	8.65e-05	0.00109	CcSEcCtD
Pamidronate—Arthralgia—Doxorubicin—bone cancer	8.65e-05	0.00109	CcSEcCtD
Pamidronate—Anxiety—Doxorubicin—bone cancer	8.62e-05	0.00108	CcSEcCtD
Pamidronate—Paraesthesia—Methotrexate—bone cancer	8.6e-05	0.00108	CcSEcCtD
Pamidronate—Discomfort—Doxorubicin—bone cancer	8.55e-05	0.00107	CcSEcCtD
Pamidronate—Anorexia—Epirubicin—bone cancer	8.54e-05	0.00107	CcSEcCtD
Pamidronate—Dyspnoea—Methotrexate—bone cancer	8.54e-05	0.00107	CcSEcCtD
Pamidronate—Somnolence—Methotrexate—bone cancer	8.51e-05	0.00107	CcSEcCtD
Pamidronate—Dyspepsia—Methotrexate—bone cancer	8.43e-05	0.00106	CcSEcCtD
Pamidronate—Hypotension—Epirubicin—bone cancer	8.38e-05	0.00105	CcSEcCtD
Pamidronate—Confusional state—Doxorubicin—bone cancer	8.36e-05	0.00105	CcSEcCtD
Pamidronate—Decreased appetite—Methotrexate—bone cancer	8.33e-05	0.00105	CcSEcCtD
Pamidronate—Anaphylactic shock—Doxorubicin—bone cancer	8.29e-05	0.00104	CcSEcCtD
Pamidronate—Oedema—Doxorubicin—bone cancer	8.29e-05	0.00104	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Methotrexate—bone cancer	8.27e-05	0.00104	CcSEcCtD
Pamidronate—Fatigue—Methotrexate—bone cancer	8.26e-05	0.00104	CcSEcCtD
Pamidronate—Infection—Doxorubicin—bone cancer	8.24e-05	0.00103	CcSEcCtD
Pamidronate—Pain—Methotrexate—bone cancer	8.19e-05	0.00103	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Epirubicin—bone cancer	8.17e-05	0.00103	CcSEcCtD
Pamidronate—Shock—Doxorubicin—bone cancer	8.16e-05	0.00102	CcSEcCtD
Pamidronate—Nervous system disorder—Doxorubicin—bone cancer	8.13e-05	0.00102	CcSEcCtD
Pamidronate—Thrombocytopenia—Doxorubicin—bone cancer	8.12e-05	0.00102	CcSEcCtD
Pamidronate—Insomnia—Epirubicin—bone cancer	8.11e-05	0.00102	CcSEcCtD
Pamidronate—Tachycardia—Doxorubicin—bone cancer	8.09e-05	0.00102	CcSEcCtD
Pamidronate—Paraesthesia—Epirubicin—bone cancer	8.05e-05	0.00101	CcSEcCtD
Pamidronate—Hyperhidrosis—Doxorubicin—bone cancer	8.02e-05	0.00101	CcSEcCtD
Pamidronate—Dyspnoea—Epirubicin—bone cancer	7.99e-05	0.001	CcSEcCtD
Pamidronate—Somnolence—Epirubicin—bone cancer	7.97e-05	0.001	CcSEcCtD
Pamidronate—Anorexia—Doxorubicin—bone cancer	7.91e-05	0.000992	CcSEcCtD
Pamidronate—Feeling abnormal—Methotrexate—bone cancer	7.89e-05	0.000991	CcSEcCtD
Pamidronate—Dyspepsia—Epirubicin—bone cancer	7.89e-05	0.000991	CcSEcCtD
Pamidronate—Gastrointestinal pain—Methotrexate—bone cancer	7.83e-05	0.000983	CcSEcCtD
Pamidronate—Decreased appetite—Epirubicin—bone cancer	7.79e-05	0.000978	CcSEcCtD
Pamidronate—Hypotension—Doxorubicin—bone cancer	7.75e-05	0.000973	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Epirubicin—bone cancer	7.74e-05	0.000972	CcSEcCtD
Pamidronate—Fatigue—Epirubicin—bone cancer	7.73e-05	0.00097	CcSEcCtD
Pamidronate—Constipation—Epirubicin—bone cancer	7.66e-05	0.000962	CcSEcCtD
Pamidronate—Pain—Epirubicin—bone cancer	7.66e-05	0.000962	CcSEcCtD
Pamidronate—Body temperature increased—Methotrexate—bone cancer	7.57e-05	0.000951	CcSEcCtD
Pamidronate—Abdominal pain—Methotrexate—bone cancer	7.57e-05	0.000951	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Doxorubicin—bone cancer	7.56e-05	0.000949	CcSEcCtD
Pamidronate—Insomnia—Doxorubicin—bone cancer	7.5e-05	0.000942	CcSEcCtD
Pamidronate—Paraesthesia—Doxorubicin—bone cancer	7.45e-05	0.000935	CcSEcCtD
Pamidronate—Dyspnoea—Doxorubicin—bone cancer	7.39e-05	0.000928	CcSEcCtD
Pamidronate—Feeling abnormal—Epirubicin—bone cancer	7.39e-05	0.000927	CcSEcCtD
Pamidronate—Somnolence—Doxorubicin—bone cancer	7.37e-05	0.000926	CcSEcCtD
Pamidronate—Gastrointestinal pain—Epirubicin—bone cancer	7.33e-05	0.00092	CcSEcCtD
Pamidronate—Dyspepsia—Doxorubicin—bone cancer	7.3e-05	0.000917	CcSEcCtD
Pamidronate—Decreased appetite—Doxorubicin—bone cancer	7.21e-05	0.000905	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Doxorubicin—bone cancer	7.16e-05	0.000899	CcSEcCtD
Pamidronate—Fatigue—Doxorubicin—bone cancer	7.15e-05	0.000898	CcSEcCtD
Pamidronate—Pain—Doxorubicin—bone cancer	7.09e-05	0.00089	CcSEcCtD
Pamidronate—Constipation—Doxorubicin—bone cancer	7.09e-05	0.00089	CcSEcCtD
Pamidronate—Body temperature increased—Epirubicin—bone cancer	7.09e-05	0.00089	CcSEcCtD
Pamidronate—Abdominal pain—Epirubicin—bone cancer	7.09e-05	0.00089	CcSEcCtD
Pamidronate—Hypersensitivity—Methotrexate—bone cancer	7.06e-05	0.000886	CcSEcCtD
Pamidronate—Asthenia—Methotrexate—bone cancer	6.87e-05	0.000863	CcSEcCtD
Pamidronate—Feeling abnormal—Doxorubicin—bone cancer	6.83e-05	0.000858	CcSEcCtD
Pamidronate—Gastrointestinal pain—Doxorubicin—bone cancer	6.78e-05	0.000851	CcSEcCtD
Pamidronate—Pruritus—Methotrexate—bone cancer	6.78e-05	0.000851	CcSEcCtD
Pamidronate—Hypersensitivity—Epirubicin—bone cancer	6.6e-05	0.000829	CcSEcCtD
Pamidronate—Abdominal pain—Doxorubicin—bone cancer	6.56e-05	0.000823	CcSEcCtD
Pamidronate—Body temperature increased—Doxorubicin—bone cancer	6.56e-05	0.000823	CcSEcCtD
Pamidronate—Diarrhoea—Methotrexate—bone cancer	6.55e-05	0.000823	CcSEcCtD
Pamidronate—Asthenia—Epirubicin—bone cancer	6.43e-05	0.000807	CcSEcCtD
Pamidronate—Pruritus—Epirubicin—bone cancer	6.34e-05	0.000796	CcSEcCtD
Pamidronate—Dizziness—Methotrexate—bone cancer	6.33e-05	0.000795	CcSEcCtD
Pamidronate—Diarrhoea—Epirubicin—bone cancer	6.13e-05	0.00077	CcSEcCtD
Pamidronate—Hypersensitivity—Doxorubicin—bone cancer	6.11e-05	0.000767	CcSEcCtD
Pamidronate—Vomiting—Methotrexate—bone cancer	6.09e-05	0.000765	CcSEcCtD
Pamidronate—Rash—Methotrexate—bone cancer	6.04e-05	0.000758	CcSEcCtD
Pamidronate—Dermatitis—Methotrexate—bone cancer	6.03e-05	0.000757	CcSEcCtD
Pamidronate—Headache—Methotrexate—bone cancer	6e-05	0.000753	CcSEcCtD
Pamidronate—Asthenia—Doxorubicin—bone cancer	5.95e-05	0.000747	CcSEcCtD
Pamidronate—Dizziness—Epirubicin—bone cancer	5.93e-05	0.000744	CcSEcCtD
Pamidronate—Pruritus—Doxorubicin—bone cancer	5.87e-05	0.000737	CcSEcCtD
Pamidronate—Vomiting—Epirubicin—bone cancer	5.7e-05	0.000715	CcSEcCtD
Pamidronate—Nausea—Methotrexate—bone cancer	5.69e-05	0.000714	CcSEcCtD
Pamidronate—Diarrhoea—Doxorubicin—bone cancer	5.67e-05	0.000712	CcSEcCtD
Pamidronate—Rash—Epirubicin—bone cancer	5.65e-05	0.00071	CcSEcCtD
Pamidronate—Dermatitis—Epirubicin—bone cancer	5.65e-05	0.000709	CcSEcCtD
Pamidronate—Headache—Epirubicin—bone cancer	5.61e-05	0.000705	CcSEcCtD
Pamidronate—Dizziness—Doxorubicin—bone cancer	5.48e-05	0.000689	CcSEcCtD
Pamidronate—Nausea—Epirubicin—bone cancer	5.32e-05	0.000668	CcSEcCtD
Pamidronate—Vomiting—Doxorubicin—bone cancer	5.27e-05	0.000662	CcSEcCtD
Pamidronate—Rash—Doxorubicin—bone cancer	5.23e-05	0.000657	CcSEcCtD
Pamidronate—Dermatitis—Doxorubicin—bone cancer	5.22e-05	0.000656	CcSEcCtD
Pamidronate—Headache—Doxorubicin—bone cancer	5.2e-05	0.000652	CcSEcCtD
Pamidronate—Nausea—Doxorubicin—bone cancer	4.93e-05	0.000618	CcSEcCtD
